BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15781669)

  • 1. Serum uric acid and target organ damage in primary hypertension.
    Viazzi F; Parodi D; Leoncini G; Parodi A; Falqui V; Ratto E; Vettoretti S; Bezante GP; Del Sette M; Deferrari G; Pontremoli R
    Hypertension; 2005 May; 45(5):991-6. PubMed ID: 15781669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of renal resistive index with target organ damage in essential hypertension.
    Doi Y; Iwashima Y; Yoshihara F; Kamide K; Takata H; Fujii T; Kubota Y; Nakamura S; Horio T; Kawano Y
    Am J Hypertens; 2012 Dec; 25(12):1292-8. PubMed ID: 22874890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia.
    Cuspidi C; Valerio C; Sala C; Meani S; Esposito A; Zanchetti A; Mancia G
    Am J Hypertens; 2007 Jun; 20(6):678-85. PubMed ID: 17531928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients.
    Leoncini G; Ratto E; Viazzi F; Vaccaro V; Parodi D; Parodi A; Falqui V; Tomolillo C; Deferrari G; Pontremoli R
    J Intern Med; 2005 May; 257(5):454-60. PubMed ID: 15836662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid and target organ damage in essential hypertension.
    Ofori SN; Odia OJ
    Vasc Health Risk Manag; 2014; 10():253-61. PubMed ID: 24833906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension.
    Leoncini G; Ratto E; Viazzi F; Vaccaro V; Parodi A; Falqui V; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    Hypertension; 2006 Sep; 48(3):397-403. PubMed ID: 16880345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The controversial role of serum uric acid in essential hypertension: relationships with indices of target organ damage.
    Tsioufis C; Chatzis D; Vezali E; Dimitriadis K; Antoniadis D; Zervoudaki A; Lalos S; Kallikazaros I; Stefanadis C; Toutouzas P
    J Hum Hypertens; 2005 Mar; 19(3):211-7. PubMed ID: 15647779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension.
    Leoncini G; Sacchi G; Ravera M; Viazzi F; Ratto E; Vettoretti S; Parodi D; Bezante GP; Del Sette M; Deferrari G; Pontremoli R
    J Hum Hypertens; 2002 Jun; 16(6):399-404. PubMed ID: 12037694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global risk stratification in primary hypertension: the role of the kidney.
    Leoncini G; Ratto E; Viazzi F; Conti N; Falqui V; Parodi A; Tomolillo C; Deferrari G; Pontremoli R
    J Hypertens; 2008 Mar; 26(3):427-32. PubMed ID: 18300851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension.
    Leoncini G; Viazzi F; Parodi D; Vettoretti S; Ratto E; Ravera M; Tomolillo C; Del Sette M; Bezante GP; Deferrari G; Pontremoli R
    Hypertension; 2003 Jul; 42(1):14-8. PubMed ID: 12756221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uricaemia and left ventricular mass in hypertensive patients.
    Catena C; Colussi G; Capobianco F; Brosolo G; Sechi LA
    Eur J Clin Invest; 2014 Oct; 44(10):972-81. PubMed ID: 25186106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased renal resistive index in patients with essential hypertension: a marker of target organ damage.
    Pontremoli R; Viazzi F; Martinoli C; Ravera M; Nicolella C; Berruti V; Leoncini G; Ruello N; Zagami P; Bezante GP; Derchi LE; Deferrari G
    Nephrol Dial Transplant; 1999 Feb; 14(2):360-5. PubMed ID: 10069189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and target organ damage in essential hypertension: role of the metabolic syndrome.
    Cuspidi C; Meani S; Valerio C; Sala C; Fusi V; Zanchetti A; Mancia G
    Am J Hypertens; 2007 Mar; 20(3):296-303. PubMed ID: 17324743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between mass of the left ventricular myocardium and uric acid metabolic imbalance in patients with arterial hypertension].
    Donskov AS; Balkarov IM; Golub' GV; Anikina SA; Saltykova NG; Sviderskaia NS; Prilepo NA; Feofanova ID
    Ter Arkh; 2001; 73(6):31-3. PubMed ID: 11521517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular hypertrophy and microalbuminuria in patients with essential hypertension.
    Monfared A; Salari A; Mirbolok F; Momeni M; Shafighnia S; Shakiba M; Sheikholeslami A
    Iran J Kidney Dis; 2013 May; 7(3):192-7. PubMed ID: 23689150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild hyperuricemia and subclinical renal damage in untreated primary hypertension.
    Viazzi F; Leoncini G; Ratto E; Falqui V; Parodi A; Conti N; Derchi LE; Tomolillo C; Deferrari G; Pontremoli R
    Am J Hypertens; 2007 Dec; 20(12):1276-82. PubMed ID: 18047917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Target organ damage in children with newly diagnosed and untreated essential hypertension].
    Antoniewicz J; Litwin M; Daszkoska J; Niemirska A; Sladowska J; Wierzbicka A; Wawer Z; Grenda R
    Przegl Lek; 2006; 63 Suppl 3():101-6. PubMed ID: 16898502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular permeability, blood pressure, and organ damage in primary hypertension.
    Viazzi F; Leoncini G; Ratto E; Parodi A; Falqui V; Conti N; Tomolillo C; Ravera G; Deferrari G; Pontremoli R
    Hypertens Res; 2008 May; 31(5):873-9. PubMed ID: 18712042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is retinal arteriolar-venular ratio associated with cardiac and extracardiac organ damage in essential hypertension?
    Masaidi M; Cuspidi C; Giudici V; Negri F; Sala C; Zanchetti A; Grassi G; Mancia G
    J Hypertens; 2009 Jun; 27(6):1277-83. PubMed ID: 19357533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical target organ damage in subjects with different components of metabolic syndrome.
    Rotar OP; Boyarinova MA; Moguchaia EV; Kolesova EP; Erina AM; Solntsev VN; Konradi AO; Shlyakhto EV
    Clin Exp Hypertens; 2018; 40(5):421-426. PubMed ID: 29068233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.